Skip to content

TOXINS 2026: Program, Registration Fees, and Abstract Rules

TOXINS 2026, the International Neurotoxin Association’s (INA) eighth international conference on the basic science and clinical aspects of botulinum and other neurotoxins, took place January 14–17, 2026, at the Madrid Marriott Auditorium Hotel & Conference Center in Madrid, Spain. Registration and abstract submission are closed. (INA conference overview 🔗)

The next identified edition is TOXINS 2028. The fees, deadlines, and requirements below are records of the completed 2026 meeting, useful for understanding its scope and preparing questions for a future edition.

The official 2026 program 🔗 retains the session timetable and a downloadable program. It combined basic science, clinical tracks, and workshops.

2026 program topicWhat the topic concernsRelated reference
Adult and pediatric spasticity; cervical dystoniaClinical treatment contexts and patient assessmentLimb spasticity, cervical dystonia
Migraine and headacheA dedicated clinical trackChronic migraine
Aesthetics and dermatologyClinical and anatomical discussionsGlabellar lines, anatomy overview
Clinical relevance of neutralizing antibodiesImmune responses and treatment responseImmunogenicity
Dosage conversion among different preparationsThe evidence question surrounding product unitsUnit interpretation
Botulinum toxin type E trials for glabellar linesResearch on another toxin typeBotulinum toxin type E
Toxin structure, neuron entry, and engineeringBasic science and experimental toxin developmentMechanism of action, toxin type differences

A program entry establishes that a topic was scheduled, not the findings of the talk or the strength of its evidence. Study conclusions require the abstract or full paper; a conference listing does not establish an approved use or a product conversion ratio.

INA’s homepage announcement 🔗 links the meeting abstracts to the Toxicon volume 271 supplement 🔗. Access conditions are controlled by the publisher. A session title is a starting point for locating research, rather than a substitute for reading its methods, results, and limitations.

The 2026 registration schedule 🔗 listed these attendee fees in US dollars:

Attendee categoryINA memberNon-member
Early bird$875$975
Regular$975$1,075
On-site$1,125$1,225
Fellows/residents and postdoctoral fellows$350$450
Students$150$250

Membership was free; academic discounts required credentials. Scientific sessions, exhibits, posters, materials, the reception, breakfast, and lunch were included. Accommodation was excluded. Exhibitor registrations were separate categories; the commercial exhibitor rate explicitly excluded session access.

2026 registration milestoneHistorical date
Early-bird registrationJune 2–August 21, 2025
Regular registration openedAugust 22, 2025
Individual/group registration closedJanuary 5, 2026, 11:59 p.m. Eastern Standard Time
On-site registration beganJanuary 14, 2026

The cancellation policy offered 50% refunds through November 5, 2025, and 25% through November 19. It stated that no cancellations would be honored after November 20, 2025. These were past booking conditions, not refund terms for 2028. (INA registration and refund policy 🔗)

The 2026 abstract instructions 🔗 set a deadline of October 24, 2025, at 11:59 p.m. Eastern Time. Submission is closed.

Requirement2026 rule
Language and lengthEnglish; body up to 500 words; up to six keywords
FileWord, Arial 12-point; no PDF
StructureStructured or unstructured abstracts accepted
Tables and figuresEditable text tables; captioned figures embedded in Word
Author informationNames, affiliations, corresponding-author contact details, and research funding
Submission routeOnline portal; email and fax not accepted
ReviewRolling; status notification expected within six weeks

Tables were excluded from the word count, as were the title, author information, footer, keywords, and financial support. The instructions linked a checklist and sample format.

Encore submissions (previously presented work) were allowed, but abstracts accepted for TOXINS 2024 required updated data. Acceptance provided for publication in a Toxicon supplement, with copyright transfer to Elsevier. Attendance and poster presentation were optional; attending authors still had to register. These are historical conditions, not confirmed 2028 requirements. (INA abstract conditions 🔗)

The official poster instructions 🔗 required registration for authors bringing a poster. Authors did not have to remain beside it during display hours.

Poster requirement2026 specification
Maximum physical size1,828 mm wide × 1,219 mm high; landscape
SetupJanuary 14, 2026, 8:00 a.m.–5:00 p.m.
MountingBoards and double-sided tape supplied; poster IDs provided on site
LogosINA, TOXINS 2026, and corporate logos excluded
Optional online posterWeb-ready PDF, maximum 2 MB; submission link requested before December 12, 2025

The optional virtual poster hall was described as available to attendees for six months after the conference. That historical access period does not establish that the posters remain available now. Abstract submission used Word; the PDF specification applied to the separate online poster.

Toxins 101 ran on January 14, 2026, from noon to 4:00 p.m. It introduced clinical neurotoxin applications for clinicians with limited experience, including trainees, and interested basic scientists. Topics included mechanisms, spasticity, movement disorders, and case discussions. (INA Toxins 101 course 🔗)

The course had limited capacity and separate signup through an email sent to registered attendees. The announcement gave December 1 as the signup opening but did not specify an additional fee. Separate signup therefore establishes a booking step, not a confirmed surcharge.

The main program 🔗 also listed ultrasound workshops for the limbs and head and neck, plus injection demonstrations across several clinical areas. These entries describe educational activities; they do not establish a qualification or replace product-specific labeling and professional training.

For the next meeting, use the TOXINS 2028 planning guide for announcement status and preparation. The events overview connects the TOXINS series with broader neurology, rehabilitation, and aesthetic medicine meetings.

1. An author’s abstract was accepted for TOXINS 2026. How did acceptance relate to attendance?
2. A program lists a talk about dosage conversion among toxin preparations. What does that listing establish?
3. Toxins 101 required separate signup through an attendee email. What can be concluded about booking?